Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL.

Nirali N. Shah,Daniel W. Lee,Bonnie Yates,Constance M. Yuan,Haneen Shalabi,Staci Martin,Pamela L. Wolters,Seth M. Steinberg,Eva H. Baker,Cindy Delbrook,Maryalice Stetler-Stevenson,Terry J. Fry,David F. Stroncek,Crystal L. Mackall

Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL.

2021

Nirali N. Shah
Daniel W. Lee
Bonnie Yates
Constance M. Yuan
Haneen Shalabi
Staci Martin
Pamela L. Wolters
Seth M. Steinberg
Eva H. Baker
Cindy Delbrook
Maryalice Stetler-Stevenson
Terry J. Fry
David F. Stroncek
Crystal L. Mackall

PURPOSECD19 chimeric antigen receptor (CD19-CAR) T cells induce high response rates in children and young adults (CAYAs) with B-cell acute lymphoblastic leukemia (B-ALL), but relapse rates are high...

Keywords:

Young adult
Internal medicine
Oncology
Medicine
long term follow up
Lymphoblastic Leukemia
CAR T-cell therapy
Chimeric antigen receptor
CD19

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations